Comparison of the safety and immunogenicity of the lyophilized Merieux seed and the World Health Organization working reference BCG vaccines in school-aged children in Senegal

Author： Guerin N.   Teulieres L.   Noba A.   Schlumberger M.   Bregere P.   Chauvin P.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.2, 1999-01, pp. : 105-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ANEMIA AND INFECTION IN SCHOOL-AGED EGYPTIAN CHILDREN

By WINHAM DONNA   HARRISON GAIL   GALAL OSMAN   EL-TOBGUI MONA  

Ecology of Food and Nutrition, Vol. 43, Iss. 1-2, 2004-01 ,pp. : 29-40

Routledge Ltd

Access to resources Recommend Favorite

Traditional and novel cardiovascular risk factors in school-aged children: A call for the further development of public health strategies with emphasis on fitness

By Ruiz Jonatan   Ortega Francisco   Meusel Dirk   Sjöström Michael  

Zeitschrift fuer Gesundheitswissenschaften, Vol. 15, Iss. 3, 2007-06 ,pp. : 171-177

Springer Publishing Company

Access to resources Recommend Favorite

Nutritional status of Kuwaiti elementary school children aged 6–10 years: comparison with the NCHS/CDC reference population

By Al-Isa Abdulwahab Naser   Moussa Mohamed A. A.  

International Journal of Food Sciences and Nutrition, Vol. 51, Iss. 4, 2000-07 ,pp. : 221-228

Informa Healthcare

Access to resources Recommend Favorite

Measuring the health and health behaviours of adolescents through cross-national survey research: recent developments in the Health Behaviour in School-aged Children (HBSC) study

By Roberts Chris   Currie Candace   Samdal Oddrun   Currie Dorothy   Smith Rebecca   Maes Lea  

Zeitschrift fuer Gesundheitswissenschaften, Vol. 15, Iss. 3, 2007-06 ,pp. : 179-186

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

By Wyeth-Ayerst ca Influenza Vaccine Study Group   Gruber W.C.   Darden P.M.   Still J.G.   Lohr J.   Reed G.   Wright P.F.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1379-1384

Elsevier

Access to resources Recommend Favorite